US 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted A61KA61K31/30A61K41/0057
Quick answer
US patent 12121580 (Antibacterial photodynamic therapy using copper-cysteamine nanoparticles) held by The Board of Regents of the University of Texas System expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/30, A61K41/0057, A61K47/12, A61K9/0014